Follow
Magin Farre Albaladejo
Magin Farre Albaladejo
Hospital Universitari Germans Trias i Pujol. Universitat Autònoma de Barcelona
Verified email at uab.cat
Title
Cited by
Cited by
Year
Drug addiction
J Cami, M Farré
New England Journal of Medicine 349 (10), 975-986, 2003
10492003
An immune-enhancing enteral diet reduces mortality rate and episodes of bacteremia in septic intensive care unit patients
C Galbán, JC Montejo, A Mesejo, P Marco, S Celaya, ...
Critical care medicine 28 (3), 643-648, 2000
6582000
Human pharmacology of MDMA: pharmacokinetics, metabolism, and disposition
R De la Torre, M Farré, PN Roset, N Pizarro, S Abanades, M Segura, ...
Therapeutic drug monitoring 26 (2), 137-144, 2004
5222004
Non‐linear pharmacokinetics of MDMA (‘ecstasy’) in humans
R De La Torre, M Farre, J Ortuno, M Mas, R Brenneisen, PN Roset, ...
British journal of clinical pharmacology 49 (2), 104-109, 2000
4932000
Structural and functional imaging studies in chronic cannabis users: a systematic review of adolescent and adult findings
A Batalla, S Bhattacharyya, M Yuecel, P Fusar-Poli, JA Crippa, S Nogue, ...
PloS one 8 (2), e55821, 2013
4862013
Cardiovascular and neuroendocrine effects and pharmacokinetics of 3, 4-methylenedioxymethamphetamine in humans
M Mas, M Farré, R De la Torre, PN Roset, J Ortuño, J Segura, J Camí
Journal of Pharmacology and Experimental Therapeutics 290 (1), 136-145, 1999
4371999
Hydroxychloroquine for early treatment of adults with mild coronavirus disease 2019: a randomized, controlled trial
O Mitjà, M Corbacho-Monné, M Ubals, C Tebé, J Peñafiel, A Tobias, ...
Clinical Infectious Diseases 73 (11), e4073-e4081, 2021
3652021
Mephedrone (4-methylmethcathinone;‘meow meow’): chemical, pharmacological and clinical issues
F Schifano, A Albanese, S Fergus, JL Stair, P Deluca, O Corazza, Z Davey, ...
Psychopharmacology 214, 593-602, 2011
3592011
Efficacy of antidepressants in substance use disorders with and without comorbid depression: a systematic review and meta-analysis
M Torrens, F Fonseca, G Mateu, M Farré
Drug and alcohol dependence 78 (1), 1-22, 2005
3502005
Hydroxytyrosol disposition in humans
E Miro-Casas, MI Covas, M Farre, M Fito, J Ortuno, T Weinbrenner, ...
Clinical chemistry 49 (6), 945-952, 2003
3392003
Postprandial LDL phenolic content and LDL oxidation are modulated by olive oil phenolic compounds in humans
MI Covas, K de la Torre, M Farré-Albaladejo, J Kaikkonen, M Fitó, ...
Free Radical Biology and Medicine 40 (4), 608-616, 2006
3382006
Effects of differing phenolic content in dietary olive oils on lipids and LDL oxidation: a randomized controlled trial
J Marrugat, MI Covas, M Fitó, H Schröder, E Miró-Casas, E Gimeno, ...
European journal of nutrition 43, 140-147, 2004
3302004
Epigallocatechin‐3‐gallate, a DYRK1A inhibitor, rescues cognitive deficits in D own syndrome mouse models and in humans
R De la Torre, S De Sola, M Pons, A Duchon, MM de Lagran, M Farré, ...
Molecular nutrition & food research 58 (2), 278-288, 2014
3292014
CYP1A2-catalyzed conversion of dietary heterocyclic amines to their proximate carcinogens is their major route of metabolism in humans
AR Boobis, AM Lynch, S Murray, R de la Torre, A Solans, M Farré, ...
Cancer research 54 (1), 89-94, 1994
3221994
Retention rate and illicit opioid use during methadone maintenance interventions: a meta-analysis
M Farré, A Mas, M Torrens, V Moreno, J Camı́
Drug and alcohol dependence 65 (3), 283-290, 2002
3002002
Human pharmacology of 3, 4-methylenedioxymeth-amphetamine (" Ecstasy"): psychomotor performance and subjective effects
J Camí, M Farré, M Mas, PN Roset, S Poudevida, A Mas, L San, ...
Journal of clinical psychopharmacology 20 (4), 455-466, 2000
2932000
Acute effects of a single, oral dose of d9-tetrahydrocannabinol (THC) and cannabidiol (CBD) administration in healthy volunteers
R Martin-Santos, J a Crippa, A Batalla, S Bhattacharyya, Z Atakan, ...
Current pharmaceutical design 18 (32), 4966-4979, 2012
2922012
Safety and efficacy of cognitive training plus epigallocatechin-3-gallate in young adults with Down's syndrome (TESDAD): a double-blind, randomised, placebo-controlled, phase 2 …
R de la Torre, S de Sola, G Hernandez, M Farré, J Pujol, J Rodriguez, ...
The Lancet Neurology 15 (8), 801-810, 2016
2862016
A cluster-randomized trial of hydroxychloroquine for prevention of Covid-19
O Mitjà, M Corbacho-Monné, M Ubals, A Alemany, C Suñer, C Tebé, ...
New England Journal of Medicine 384 (5), 417-427, 2021
2852021
Alcohol and cocaine interactions in humans.
M Farré, R De la Torre, M Llorente, X Lamas, B Ugena, J Segura, J Camí
Journal of Pharmacology and Experimental Therapeutics 266 (3), 1364-1373, 1993
2781993
The system can't perform the operation now. Try again later.
Articles 1–20